secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phreesia, Inc. (PHR)
CIK:        0001412408
Form:       8-K
Filed at:   2022-06-02T23:59:59+00:00
Accession:  0001412408-22-000034
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phreesia Q1 revenue $63.4M (+31% YoY); FY23 Adj. EBITDA guidance raised to -$126M to -$122M
--------------------------------------------------------------------------------

- Revenue $63.4M vs $48.3M YoY; client count 2,526 (+33% YoY); avg. rev. per client $19,193 (-5% YoY).
- Adjusted EBITDA -$30.6M vs +$0.1M YoY; cash $269.2M, down $44.6M from Jan 2022.
- FY23 revenue outlook maintained $271M-$275M; Adj. EBITDA outlook raised to -$126M to -$122M from -$154M to -$149M.
- Company expects FY23 Adj. EBITDA to be low mark for FY23-FY25, targeting profitability in FY2025.
- Life sciences revenue $16.3M; patient payment volume $837M (+19% YoY).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412408/000141240822000034/0001412408-22-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412408/000141240822000034/phr-20220602.htm
  HTML page:      https://secwatch.observer/filing/0001412408-22-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer